Eleni Dimitriou
Overview
Explore the profile of Eleni Dimitriou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chatziralli I, Agapitou C, Dimitriou E, Kapsis P, Kazantzis D, Risi-Koziona A, et al.
Cureus
. 2024 Sep;
16(8):e66638.
PMID: 39258085
Purpose: The purpose of this study is to investigate the prevalence of vitreoretinal interface (VRI) disorders in patients with retinal vein occlusion (RVO) and to evaluate the impact of VRI...
2.
Pantelidou M, Dimitriou E, Gkontopoulos K, Thomopoulos T, Pappa V, Papageorgiou S, et al.
J Hematol
. 2024 Sep;
13(4):164-167.
PMID: 39247062
Multiple myeloma is a plasma cell dyscrasia with an age-standardized incidence of 3 - 4 per 100,000 in the Caucasian population. It is the second most common hematological malignancy after...
3.
Chatziralli I, Dimitriou E, Agapitou C, Kazantzis D, Kapsis P, Morogiannis N, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137367
Background: The purpose of this study was to investigate the changes in macular microvasculature using optical coherence tomography angiography (OCTA) in association with functional changes in patients with proliferative diabetic...
4.
Blazaki S, Blavakis E, Chlouverakis G, Bontzos G, Chatziralli I, Smoustopoulos G, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 Aug;
261(12):3425-3436.
PMID: 37566302
Purpose: Τo evaluate the evolution of macular atrophy (MA) in patients with neovascular AMD (nAMD), compared with their fellow eyes exhibiting dry AMD (dAMD). Methods: This retrospective study included 124...
5.
Chatziralli I, Agapitou C, Dimitriou E, Kapsis P, Kazantzis D, Machairoudia G, et al.
Semin Ophthalmol
. 2023 Aug;
39(1):96-101.
PMID: 37539994
Purpose: To evaluate the efficacy and safety of intravitreal aflibercept injections for diabetic macular edema (DME) treatment in a tertiary referral center in Greece. Methods: ADMIRE was a prospective, observational...
6.
Kapsis P, Agapitou C, Dimitriou E, Theodossiadis P, Chatziralli I
Cureus
. 2023 May;
15(4):e38172.
PMID: 37252587
A 65-year-old male patient presented to the ED complaining of blurred vision in the left eye for the last three days. The patient had just recovered from COVID-19 infection and...
7.
Kazantzis D, Sergentanis T, Machairoudia G, Dimitriou E, Kroupis C, Theodossiadis G, et al.
Ophthalmol Ther
. 2023 Feb;
12(2):1239-1249.
PMID: 36806996
Introduction: The aim of this study was to investigate the possible correlation between peripheral blood biomarkers and morphological characteristics of retinal imaging in patients with retinal vein occlusion (RVO). Methods:...
8.
Bourouki E, Dimitriou E, Chatzipantelis A, Kapsis P, Theodossiadis G, Theodossiadis P, et al.
Cureus
. 2022 Dec;
14(11):e31051.
PMID: 36475145
Purpose: To investigate the co-existence of diabetic retinopathy (DR) and age-related macular degeneration (AMD), based on five-year data in a University setting. Methods: Participants in the study included 1739 patients...
9.
Chatziralli I, Kazantzis D, Kroupis C, Machairoudia G, Dimitriou E, Theodossiadis G, et al.
Int Ophthalmol
. 2022 May;
42(11):3449-3457.
PMID: 35538256
Aims: To investigate potential laboratory and imaging biomarkers as treatment response predictors to intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in patients with retinal vein occlusion (RVO). Methods: Participants in...
10.
Chatziralli I, Dimitriou E, Lambadiari V, Kazantzis D, Kapsis P, Theodossiadis G, et al.
Semin Ophthalmol
. 2022 Apr;
37(5):668-675.
PMID: 35468026
Purpose: To investigate potential laboratory and imaging biomarkers as treatment response predictors to intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in patients with diabetic macular edema (DME). Methods: The study...